AI-Driven Discovery of Highly Specific and Efficacious hCES2A Inhibitors for Ameliorating Irinotecan-Triggered Gut Toxicity
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.4c02560 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Zhipei Sang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Tropical Biological Resources of Ministry of Education and One Health Institute, School of Pharmaceutical Sciences, Hainan Universi…. Hauptthemen laut MEDLINE: Irinotecan, Carboxylesterase. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Natural Science Foundation of Hainan Province, Hainan University.
Abstract (Originalsprache)
The anticancer agent irinotecan often induces severe delayed-onset diarrhea, inhibiting human carboxylesterase 2A (hCES2A) can significantly alleviate irinotecan-triggered gut toxicity (ITGT). This work presents an efficient workflow for de novo design and developing novel efficacious hCES2A inhibitors. A well-training machine learning model identified scaffold-14 as a lead compound, while compound 14n was developed as a novel time-dependent hCES2A inhibitor (IC50 = 0.04 nM) following three rounds of structural optimization. The covalent binding modes and inactivation mechanisms of 14n were elucidated by nanoLC-MS/MS-based chemoproteomics and covalent docking simulations. Notably, 14n showed excellent selectivity, good cell-membrane permeability, favorable drug-like properties, and potent inhibition on intracellular hCES2A. In vivo tests demonstrated that 14n was orally active, showing favorable safety profiles and impressive ameliorative effects on ITGT in tumor-bearing mice. Collectively, this work showcases a high-efficient AI-driven strategy for developing novel efficacious hCES2A inhibitors, while 14n emerges as a promising candidate for alleviating ITGT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Tropical Biological Resources of Ministry of Education and One Health Institute, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China.
- State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine; Shanghai Frontiers Science Center of TCM Chemical Biology; Institute of Interdisciplinary Integrative Medicine…
- Department of Pharmacy, Jingan District Zhabei Central Hospital, Shanghai 200070, China.
- College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, China.
ORCID-Profile: Guangbo Ge
Förderung
- China Postdoctoral Science Foundation
- Natural Science Foundation of Hainan Province
- Hainan University
- Shanghai University of Traditional Chinese Medicine
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China
Zitieren
APA
Sang, Z., Zhang, Y., Fan, Y., Luan, C., Liu, Z., Zhang, Q., Zeng, H., Song, Y., Huang, S., & Ge, G. (2025). AI-Driven Discovery of Highly Specific and Efficacious hCES2A Inhibitors for Ameliorating Irinotecan-Triggered Gut Toxicity. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c02560
Vancouver
Sang Z, Zhang Y, Fan Y, Luan C, Liu Z, Zhang Q, et al. AI-Driven Discovery of Highly Specific and Efficacious hCES2A Inhibitors for Ameliorating Irinotecan-Triggered Gut Toxicity. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c02560
BibTeX
@article{Sang2025,
author = {Sang, Zhipei and Zhang, Ya and Fan, Yufan and Luan, Changhai and Liu, Zhengwei and Zhang, Qiyao and Zeng, Hairong and Song, Yunqing and Huang, Shuheng and Ge, Guangbo},
title = {AI-Driven Discovery of Highly Specific and Efficacious hCES2A Inhibitors for Ameliorating Irinotecan-Triggered Gut Toxicity},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.4c02560}
}
EUVIMED